Professor Christopher Bartlett in his written statement to the Archer Inquiry, referring to Dr Galbraith's letter and paper of the 9 May 1983, explained that Dr Galbraith had sought his opinion on the final drafts and that he fully concurred with the conclusions and advice he had expressed.
Chronology Information
Date:
Chapter/issue
Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates
Key Person(s)
Dr Nicol Spence Galbraith